Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.15 USD | -7.18% | +3.55% | +58.69% |
15/05 | Spyre Therapeutics, Inc. Announces Board Changes | CI |
13/05 | Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.69% | 186.83Cr | |
+16.73% | 12TCr | |
+13.04% | 11TCr | |
-5.80% | 2.48TCr | |
+1.69% | 2.25TCr | |
-10.09% | 1.83TCr | |
-40.52% | 1.63TCr | |
-14.00% | 1.53TCr | |
+1.18% | 1.41TCr | |
+24.18% | 1.17TCr |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Transcript : Aeglea BioTherapeutics, Inc. - Special Call